# Amorepacific Corporation – FDA Inspection, Mar 16, 2024

Source: https://www.keypedia.com/records/fda_inspections/amorepacific-corporation/fe837471-5954-413b-8256-a73400e39ae3
Source feed: FDA_Inspections

> FDA inspection 1233111 of Amorepacific Corporation, March 16, 2024. Classification: Voluntary Action Indicated (VAI). 5 citations under 21 CFR part 211.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1233111
- Company Name: Amorepacific Corporation
- Inspection Date: 2024-03-16
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 5

## Related Officers

- [Arsen Karapetyan](https://www.keypedia.com/people/arsen-karapetyan/4000d909-277b-4533-992f-4e3627c8ce40)
- [FDA Associated Person](https://www.keypedia.com/people/brittny-c-cargo/a3479241-5390-4ddb-b892-df0bac1c89cf)

Company: https://www.keypedia.com/companies/amorepacific-corporation/b6fdbd13-58d6-41dc-bc51-5c2a82f9aa4e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c